146 related articles for article (PubMed ID: 12725186)
21. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
22. [Express of transforming growth factor alpha and beta1 in cholesteatoma tissue].
Li WR; Chen ZN
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Dec; 40(12):935-6. PubMed ID: 16874966
[No Abstract] [Full Text] [Related]
23. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
24. [DNA character of the cholesteatoma].
Cui Y; Pan H; Gao Q
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):62-3. PubMed ID: 12541864
[TBL] [Abstract][Full Text] [Related]
25. [Keratinocyte growth factor and its receptor in middle-ear cholesteatoma].
Guzińska-Ustymowicz K; Kurzyna A; Trzpis K; Kemona A; Hassmann-Poznańska E
Otolaryngol Pol; 2013; 67(2):67-71. PubMed ID: 23452652
[TBL] [Abstract][Full Text] [Related]
26. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
Li S; Zhan H; Peng S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
[TBL] [Abstract][Full Text] [Related]
27. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
Schilling V; Bujia J; Negri B; Kastenbauer E
Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
[TBL] [Abstract][Full Text] [Related]
28. Some markers of proliferative activity in cholesteatoma epithelium in adults.
Olszewska E; Chodynicki S; Chyczewski L; Rogowski M
Med Sci Monit; 2006 Aug; 12(8):CR337-40. PubMed ID: 16865065
[TBL] [Abstract][Full Text] [Related]
29. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of middle ear mucosa residues in cholesteatoma samples.
Sudhoff H; Bujía J; Holly A; Kim C; Fisseler-Eckhoff A
Am J Otol; 1994 Mar; 15(2):217-21. PubMed ID: 8172304
[TBL] [Abstract][Full Text] [Related]
31. [Markers of epidermal proliferation in middle ear cholesteatoma].
Hassmann-Poznańska E; Skotnicka B; Dziecioł J
Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
[TBL] [Abstract][Full Text] [Related]
32. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Li Y; Xu Z; Zhang L; Quan C; Lin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
[TBL] [Abstract][Full Text] [Related]
33. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical studies of vascularization of cholesteatoma].
Stammberger M; Holly A; Bujia J
Laryngorhinootologie; 1993 Apr; 72(4):170-3. PubMed ID: 7684226
[TBL] [Abstract][Full Text] [Related]
35. Involvement of interleukin-1 in middle ear cholesteatoma.
Shiwa M; Kojima H; Kamide Y; Moriyama H
Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
[TBL] [Abstract][Full Text] [Related]
36. [New aspects on the pathogenesis of cholesteatoma: the possible role of immune cell-induced keratinocyte hyperproliferation].
Bujía J; Holly A; Kim C; Schilling V; Kastenbauer E
Laryngorhinootologie; 1993 Jun; 72(6):279-83. PubMed ID: 8333881
[TBL] [Abstract][Full Text] [Related]
37. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
Liu D; Ma X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
[TBL] [Abstract][Full Text] [Related]
38. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
[TBL] [Abstract][Full Text] [Related]
40. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
